Meta-analysis of cognitive function in vortioxetine clinical trials in major depressive disorder

被引：0
|
作者：
McIntyre, R. [1 ]
Harrison, J. [2 ,3 ,4 ]
Loft, H. [5 ]
Jacobson, W. [6 ]
Olsen, C. [5 ]
机构：
[1] Univ Toronto, Mood Disorders Psychopharmacol Unit, Toronto, ON, Canada
[2] Metis Cognit Ltd, Kilmington, Common, England
[3] Univ London Imperial Coll Sci Technol & Med, London, England
[4] Metis Cognit Ltd, London, England
[5] H Lundbeck & Co AS, Brintellix Clin Sci, Copenhagen, Denmark
[6] Takeda Dev Ctr Amer, Global Clin Sci, Deerfield, IL USA
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2015年 / 25卷
关键词：
D O I：
10.1016/S0924-977X(15)30621-0
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P.2.h.011
引用
收藏
页码：S459 / S460
页数：2
相关论文
共 50 条
  • [21] Efficacy of anti-inflammatory treatment on major depressive disorder or depressive symptoms: meta-analysis of clinical trials
    Kohler-Forsherg, O.
    Lydholm, C. N.
    Hjorthoj, C.
    Nordentoft, M.
    Mors, O.
    Benros, M. E.
    ACTA PSYCHIATRICA SCANDINAVICA, 2019, 139 (05) : 404 - 419
  • [22] Change in Cognitive Function over the Course of Major Depressive Disorder: A Systematic Review and Meta-analysis
    Ahern, Elayne
    White, Jessica
    Slattery, Eadaoin
    NEUROPSYCHOLOGY REVIEW, 2024, 35 (1) : 1 - 34
  • [23] A meta-analysis of cognitive functions in children and adolescents with major depressive disorder
    Stefanie Wagner
    Carmen Müller
    Isabella Helmreich
    Michael Huss
    André Tadić
    European Child & Adolescent Psychiatry, 2015, 24 : 5 - 19
  • [24] A meta-analysis of cognitive functions in children and adolescents with major depressive disorder
    Wagner, Stefanie
    Mueller, Carmen
    Helmreich, Isabella
    Huss, Michael
    Tadic, Andre
    EUROPEAN CHILD & ADOLESCENT PSYCHIATRY, 2015, 24 (01) : 5 - 19
  • [25] Effects of vortioxetine on cognitive symptoms of major depressive disorder (MDD)
    Fava, M.
    Lophaven, S.
    Olsen, C.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2014, 17 : 61 - 61
  • [26] The efficacy and safety of 5 mg/d Vortioxetine compared to placebo for major depressive disorder: A meta-analysis
    Fu, Jie
    Chen, Yangmei
    PSYCHOPHARMACOLOGY, 2015, 232 (01) : 7 - 16
  • [27] A population pharmacokinetic (PK)-pharmacodynamic (PD) meta-analysis of vortioxetine in patients with major depressive Disorder (MDD)
    Areberg, Johan
    Chan, Serena
    Vakilynejad, Mayid
    Chen, Grace
    Loft, Henrik
    Mahableshwarkar, Atul
    Naik, Himanshu
    INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2013, 17 : 13 - 13
  • [28] Efficacy of vortioxetine in the treatment of cognitive symptoms of major depressive disorder
    Romero Guillena, S. L.
    Plasencia Garcia de Diego, B. O.
    Santamaria, O.
    Gotor Sanchez-Luengo, F.
    Navarro, R.
    EUROPEAN PSYCHIATRY, 2018, 48 : S206 - S206
  • [29] The efficacy and safety of 5 mg/d Vortioxetine compared to placebo for major depressive disorder: A meta-analysis
    Jie Fu
    Yangmei Chen
    Psychopharmacology, 2015, 232 : 7 - 16
  • [30] Effectiveness and Safety of Vortioxetine for the Treatment of Major Depressive Disorder in the Real World: A Systematic Review and Meta-Analysis
    Li, Zejun
    Liu, Shouhuan
    Wu, Qiuxia
    Li, Jing
    Yang, Qian
    Wang, Xin
    Peng, Pu
    Wang, Qianjin
    Liu, Yueheng
    Li, Manyun
    Hao, Yuzhu
    Xu, Huixue
    He, Li
    Wang, Yunfei
    Chen, Shubao
    Liu, Tieqiao
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2023, 26 (06): : 373 - 384
12345